| Autor: |
Prazeres Tavares, Hamilton dos, Meirelles dos Santos, Débora Cristina Damasceno, Abbade, Joelcio Francisco, Negrato, Carlos Antonio, de Campos, Paulo Adão, Paranhos Calderon, Iracema Mattos, Cunha Rudge, Marilza Vieira |
| Předmět: |
|
| Zdroj: |
Diabetology & Metabolic Syndrome; 3/22/2016, Vol. 8, p1-12, 12p, 9 Charts |
| Abstrakt: |
Background: Metabolic syndrome (MetS) is a cluster of risk factors for type 2 diabetes (Type2 DM) and cardiovascular diseases (CVD), and its prevalence varies based on region, population, and sex. Newborns of women with MetS have a greater risk of adverse perinatal outcomes. This study explores the prevalence of metabolic syndrome in non-diabetic, pregnant Angolan women and the adverse perinatal outcomes associated with it. Methods: This cross-sectional study collected the demographic, anthropometric and clinical data of 675 pregnant women in the maternity ward of General Hospital in Huambo, Angola. Metabolic syndrome was defined using four criteria: the third report of the National Cholesterol Education Program Adult Treatment Panel (ATPIII), the Joint Interim Statement (JIS), and definitions by both Bartha et al. and Chatzi et al. Results: The crude prevalence of metabolic syndrome was 36.6% based on the JIS definition, 29.2% based on NCEP ATPIII, 12.6% based on Chatzi et al. and 1.8% based on Bartha et al. In general, the prevalence of adverse perinatal outcomes was 14.1%. Conclusions: There was a high prevalence of metabolic syndrome, depending on the criteria used, and thus a great need to harmonize the criteria and cutoff points. Perinatal adverse outcomes were higher in pregnant women with metabolic syndrome. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
